Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.39
-0.01
(-0.01%)
After-Hours: 20:00
Haemonetics Total Assets (Quarterly) : 2.365B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.365B |
| March 31, 2026 | 2.396B |
| December 31, 2025 | 2.491B |
| September 30, 2025 | 2.442B |
| June 30, 2025 | 2.462B |
| March 31, 2025 | 2.451B |
| December 31, 2024 | 2.531B |
| September 30, 2024 | 2.525B |
| June 30, 2024 | 2.541B |
| March 31, 2024 | 2.196B |
| December 31, 2023 | 2.200B |
| September 30, 2023 | 2.011B |
| June 30, 2023 | 1.962B |
| March 31, 2023 | 1.935B |
| December 31, 2022 | 1.878B |
| September 30, 2022 | 1.865B |
| June 30, 2022 | 1.821B |
| March 31, 2022 | 1.860B |
| December 31, 2021 | 1.831B |
| September 30, 2021 | 1.801B |
| June 30, 2021 | 1.794B |
| March 31, 2021 | 1.820B |
| December 31, 2020 | 1.318B |
| September 30, 2020 | 1.418B |
| June 30, 2020 | 1.433B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.267B |
| December 31, 2019 | 1.238B |
| September 30, 2019 | 1.191B |
| June 30, 2019 | 1.260B |
| March 31, 2019 | 1.275B |
| December 31, 2018 | 1.228B |
| September 30, 2018 | 1.266B |
| June 30, 2018 | 1.241B |
| March 31, 2018 | 1.237B |
| December 31, 2017 | 1.312B |
| September 30, 2017 | 1.271B |
| June 30, 2017 | 1.251B |
| March 31, 2017 | 1.239B |
| December 31, 2016 | 1.306B |
| September 30, 2016 | 1.335B |
| June 30, 2016 | 1.317B |
| March 31, 2016 | 1.319B |
| December 31, 2015 | 1.336B |
| September 30, 2015 | 1.419B |
| June 30, 2015 | 1.427B |
| March 31, 2015 | 1.485B |
| December 31, 2014 | 1.474B |
| September 30, 2014 | 1.475B |
| June 30, 2014 | 1.477B |
| March 31, 2014 | 1.514B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 45.22B |
| Integra LifeSciences Holdings Corp. | 3.563B |
| Globus Medical, Inc. | 5.488B |
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.528B |
| Shareholders Equity (Quarterly) | 837.10M |
| Debt to Equity Ratio | 1.403 |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | 0.64% |